Regulatory Rapporteur March 2006

<< back to list of Issues

Front Cover
Volume 3 Issue 3

In This Issue

  • Advanced Therapy Medicinal Products
  • Homeopathic Medicines
  • Increase your word power - biotechnology definitions
  • Re-use of single devices
  • 10 years of EMEA CNS medicines - a new dual action antidepressant

Please login to view member only articles. Non-members may download the public articles.

TitleDownloadCategorySizeFile
Regulatory Rapporteur March 2006MembersFull Issue4MBPDF
Insights into the new proposed EU Regulation on Advanced Therapy Medicinal ProductsPublic176KBPDF
10 years of EMEA CNS medicines Part 4: Cymbalta/Xeristar (Duloxetine) a new dual action antidepressantMembers267KBPDF
Biotechnology definitions I to QMembers241KBPDF
EU Regulatory Intelligence: Updates January– February 2006Members123KBPDF
Good Pharmacovigilance Practices French decree (arrêté) of April 28, 2005 Responsibilities of pharmaceutical firmsMembers200KBPDF
Homeopathic regulation – the new way forward in EuropeMembers159KBPDF
New EU Regulation on Advanced TherapyMembers97KBPDF
New pricing system for pharmaceutical productsMembers160KBPDF
Re-use of single use devices: A threat to patient safetyMembers372KBPDF
The Exchange: Co-ordinated by Origin Pharmaceutical Services LimitedMembers384KBPDF